As a subsidiary of Aditxt, Adimune continues to advance its novel immune modulation therapy, the ADI platform, for autoimmune diseases toward first-in-human clinical trials. Aditxt provides ...
Analog Devices (ADI) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.73 per share a year ago.
Viti Roofing Devo Babas are the champions of the Fiji Bitter Savusavu 7s after defeating TEMC Warriors 15-7 in the final this afternoon. The Devo Babas have won back-to-back tournaments in Vanua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback